| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 03/01/2005 | US6861444 Treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; adrenergic blocking agents |
| 03/01/2005 | CA2289221C Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein |
| 02/24/2005 | WO2005016937A1 A SYNTHETIC METHOD FOR 6-CHLORO-4-HYDROXY-2-METHYL-2H-THIENO (2,3-e)-1,2-THIAZINE1, 1-DIOXIDE-3-CARBOXYLATE |
| 02/24/2005 | WO2005016909A1 Substituted thiophenes and uses thereof |
| 02/24/2005 | WO2005016870A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 02/24/2005 | WO2005016868A2 Matrix metalloproteinase inhibitors |
| 02/24/2005 | WO2005016867A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | US20050043573 Methods, systems and catalysts for use in aromatic alkylation reactions |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043370 Therapy for acquired immune deficiency or aids related complex; compound containing ketone and carboxy groups |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043294 Treating atherosclerosis and other coronary artery diseases; preventing dyslipidemia |
| 02/24/2005 | US20050040394 Semiconductor polymers and devices thereof |
| 02/24/2005 | DE10302452B4 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535652A1 Substituted thiophenes and uses thereof |
| 02/23/2005 | EP1508556A1 Aromatic alkylation process in the presence of a, sulfonated, halogenated and base treated styrene DVB copolymer catalyst. |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP0883612B1 Thiol derivatives with metallopeptidase (ace/nep) inhibitory activity |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1583741A Preparation of 3-alkylthiophene |
| 02/23/2005 | CN1583722A Heterofluorene highly branched derivative with strong two photon absorption characteristics |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858647 Administering retinoid such as, 6-(3-(1-Adamantyl)-4-methoxy-5-hydroxyphenyl)-2-naphthoic acid benzoic acid for therapy of and prophylaxis of bacterial infection |
| 02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | CA2289220C Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014525A2 Bi-aryl compound having immunosuppressive activity |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | US20050038248 Chemotherapeutic agents |
| 02/17/2005 | US20050038104 Substitute benzothiophene compounds |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038031 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 02/17/2005 | US20050038028 Hydroxyethylene compounds with asp2 inhibitory activity |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/17/2005 | US20050035333 organic semiconductors, for example, 5,5'-bis(2-anthracenyl)-2,2'-bithiophene; provide stable and reproducible electrical characteristics; thin film transistors or transistor arrays, and electroluminescent lamps. |
| 02/16/2005 | EP1506965A1 Propanolamine derivatives, process for preparation of 3-n-methylamino-1-(2-thienyl)-1-propanols and process for preparation of propanolamine derivatives |
| 02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505966A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 02/16/2005 | EP1505962A2 Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1253917B1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 02/16/2005 | EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1580059A 6-chloro-4-hydroxy-2-methyl-2H-thieno-(2, 3-e)-1, 2-thiazine-1, 1-dioxide-3 |
| 02/16/2005 | CN1580054A Pentatomic sulphur heterocyclic compound and its use for preparing medicine for treating preventing diseases related to adiposity |
| 02/16/2005 | CN1580043A Anti malignant tumour southern radix bupleuri extract preparing method |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189170C Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855842 Nitrating a 2-(2-formylphenoxy) or 2-(2-formylphenylsulfido) alkyl ester or alkoic acid in the presence of sulfuric acid |
| 02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855476 Produce a fluorinated alkyl sulfonic acid having a short perfluoroalkyl chain attached to an ether linkage. This ether linkage connects the fluorinated alkyl portion of the molecule with a variety of other substituents. |
| 02/15/2005 | CA2303764C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 02/10/2005 | WO2005012284A1 4,5-DIHYDRONAPHTHO[1,2-b]THIOPHENE DERIVATIVE |
| 02/10/2005 | WO2005012283A1 Substituted benzothiophene compounds and uses thereof |
| 02/10/2005 | WO2005012282A1 Novel 2-thiosubstituted benzothiophene derivatives, method for production of and pharmaceutical compositions comprising the same |
| 02/10/2005 | WO2005012280A1 Alkynyl aryl carboxamides |
| 02/10/2005 | WO2005012232A2 Hydrazide derivatives as prostaglandin receptors modulators |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | US20050033076 Coordination polymerization catalysts |
| 02/10/2005 | US20050033039 Compounds with perfluoroalkanoacetophenone groups that form complexes with rare earth elements that can be used in immunoassays or nucleic acid assays for labeling a protein, peptide, amino acid, nucleic acid, or nucleotide |
| 02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | US20050032840 Administering the analgesic, 2-methyl-1-(1-piperidinyl)-(2-thienyl)cyclohexane (gacyclidine), by itself or in conjuction with another analgesic; prevention and/or treating pain and/or nociception; preventing hyperalgias and/or allodynias induced by an analgesic acting on opiate receptors |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032798 Diaryl ureas, which release urea compound when administered to patient, for example, 1-(4-chloro-3(trifluoromethyl)phenyl)-3-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)-2-oxo-(1,3,5-perhydrotriazapine); treatment of cancer, inflammation |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050029705 Extrusion die |
| 02/10/2005 | CA2534127A1 Substituted benzothiophene compounds and uses thereof |
| 02/10/2005 | CA2529123A1 Hydrazide derivatives as prostaglandin receptors modulators |
| 02/10/2005 | CA2527861A1 Alkynyl aryl carboxamides |
| 02/09/2005 | EP1505054A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 02/09/2005 | EP1503986A2 Compositions and methods for treating heart failure |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1392675B1 Substituted oxime derivatives and the use thereof as latent acids |
| 02/09/2005 | EP1349846B1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect |
| 02/09/2005 | EP1200076A4 Calcilytic compounds |
| 02/09/2005 | EP0900210B1 Antivirally active heterocyclic azahexane derivatives |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |